FindTrial
Sign In

A medical records based study for the impact of intravesical recurrence on cancer specific survival of after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma

The impact of intravesical recurrence on cancer specific survival of after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044534
Enrollment
Unknown
Registered
2021-03-23
Start date
2021-03-25
Completion date
Unknown
Last updated
2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper urinary tract urothelial carcinoma

Interventions

Intravesical recurrence group:adical Nephroureterectomy
Non-intravesical recurrence group:adical Nephroureterectomy

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: The patients who were over 18 years old, diagnosed as upper urinary tract urothelial carcinoma, including renal pelvis cancer and ureteral cancer, and confirmed as urothelial carcinoma by postoperative pathology, patients underwent radical nephroureterectomy in our hospital.

Exclusion criteria

Exclusion criteria: Patients had neoadjuvant chemotherapy, with distant metastasis, incomplete follow-up data, concomitant tumors or tumor history in other organs, had radical cystectomy, with renal failure.

Design outcomes

Primary

MeasureTime frame
Intravesical recurrence time;Cancer specific survival;—

Countries

China

Contacts

Public Contactxu chuanliang

Shanghai Changhai Hospital

drxuchuanliang@126.com+86 21-31161716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026